박진우 (국립목포대학교)님 | 한빛사연구자 > 한빛사

국립목포대학교

CV File

최종업데이트 2026.01.09.

Ligand-directed oral lipidic nanoplatform enables sustained ferroptosis and immune reprogramming via multivalent transporter-mediated metronomic delivery
- Theranostics, Published 2026-1-1; 16(6):2952-2983. doi:10.7150/thno.124189
- 2026-01
- 의약학
- 한빛사논문
An oral liraglutide nanomicelle formulation conferring reduced insulin-resistance and long-term hypoglycemic and lipid metabolic benefits
- J. Control. Release, Dec 26 2024, 378 S0168-3659(24)00891-5 | https://doi.org/10.1016/j.jconrel.2024.12.039
- 2024-12
- 의약학
- 한빛사논문
Immune modulation of the liver metastatic colorectal cancer microenvironment via the oral CAPOX-mediated cGAS-STING pathway
- Biomaterials, May 25 2024, 310 S0142-9612(24)00159-5 | https://doi.org/10.1016/j.biomaterials.2024.122625
- 2024-05
- 생명과학
- 한빛사논문
Design of chimeric GLP-1A using oligomeric bile acids to utilize transporter-mediated endocytosis for oral delivery.
- Biomater. Res., Sep 02 2023, 27 (1) 83 | https://doi.org/10.1186/s40824-023-00421-7
- 2023-09
- 바이오·의료융합
- 한빛사논문
Oral lymphatic delivery of alpha-galactosylceramide and ovalbumin evokes anti-cancer immunization
- J. Control. Release, 2023 Apr;356:507-524 | https://doi.org/10.1016/j.jconrel.2023.03.010
- 2023-04
- 의약학
- 한빛사논문
Enhanced oral absorption of teriparatide with therapeutic potential for management of osteoporosis
- J. Control. Release, Volume 349, September 2022, Pages 502-519 | https://doi.org/10.1016/j.jconrel.2022.07.012
- 2022-09
- 의약학
- 한빛사논문
A novel oral metronomic chemotherapy provokes tumor specific immunity resulting in colon cancer eradication in combination with anti-PD-1 therapy
- Biomaterials, Available online 27 December 2021, 121334 | https://doi.org/10.1016/j.biomaterials.2021.121334
- 2021-12
- 생명과학
- 한빛사논문

연구자 ID

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기